iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 us Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time The FDA has approved the

Mateen S, Moin S, Khan AQ, et al

Fatigue or Dizziness Some individuals report temporary fatigue, lightheadedness, or low energy early during treatment

Berliner Klin Wochenschr

28 The proportion of patients with at least 1 pharmacy claim for hypotensive agents, antilipemic agents, renin-angiotensin-aldosterone system inhibitors, antibacterial agents, analgesics and antipyretics, devices, diabetic testing supplies, diuretics, sympatholytic agents, psychotherapeutic agents, and -adrenergic agents during the pre-index period was calculated

In conclusion, our study conducted within real-world clinical settings revealed a noteworthy association between the use of GLP-1 RAs, including Liraglutide and Semaglutide, and a heightened risk of psychiatric outcomes, encompassing depression, anxiety, and suicidal behaviour

The volume of medication and small needle size make this a relatively painless and bloodless injection.